Cargando…

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation

The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Giustozzi, Michela, Vedovati, Maria Cristina, Verso, Melina, Scrucca, Luca, Conti, Serenella, Verdecchia, Paolo, Bogliari, Giulio, Pierpaoli, Lucia, Agnelli, Giancarlo, Becattini, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660568/
https://www.ncbi.nlm.nih.gov/pubmed/31372440
http://dx.doi.org/10.1016/j.dib.2019.103794
_version_ 1783439323854536704
author Giustozzi, Michela
Vedovati, Maria Cristina
Verso, Melina
Scrucca, Luca
Conti, Serenella
Verdecchia, Paolo
Bogliari, Giulio
Pierpaoli, Lucia
Agnelli, Giancarlo
Becattini, Cecilia
author_facet Giustozzi, Michela
Vedovati, Maria Cristina
Verso, Melina
Scrucca, Luca
Conti, Serenella
Verdecchia, Paolo
Bogliari, Giulio
Pierpaoli, Lucia
Agnelli, Giancarlo
Becattini, Cecilia
author_sort Giustozzi, Michela
collection PubMed
description The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older with non-valvular atrial fibrillation treated with oral anticoagulants. Here, we describe the time course of ischemic stroke and systemic embolism and of major bleeding according to the presence of outcome predictors and report the causes of permanent discontinuation and of death. Furthermore, we report data on the incidence of ischemic stroke and systemic embolism, of major bleeding, of permanent discontinuation and of all-cause death comparing i) oral anticoagulant naïve users vs. long-term oral anticoagulant users, ii) patients on anticoagulant therapy for less than 2 years (new users) vs. patients on anticoagulant therapy for more than 2 years. The material of this data article provides a better understanding on the use of oral anticoagulants in this fragile population and facilitates further critical analysis. Moreover, it aims at highlighting the importance of increasing knowledge in patients aged 90 years or older. These patients are often excluded from or under-represented in clinical trials and cohort studies.
format Online
Article
Text
id pubmed-6660568
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66605682019-08-01 Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation Giustozzi, Michela Vedovati, Maria Cristina Verso, Melina Scrucca, Luca Conti, Serenella Verdecchia, Paolo Bogliari, Giulio Pierpaoli, Lucia Agnelli, Giancarlo Becattini, Cecilia Data Brief Medicine and Dentistry The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older with non-valvular atrial fibrillation treated with oral anticoagulants. Here, we describe the time course of ischemic stroke and systemic embolism and of major bleeding according to the presence of outcome predictors and report the causes of permanent discontinuation and of death. Furthermore, we report data on the incidence of ischemic stroke and systemic embolism, of major bleeding, of permanent discontinuation and of all-cause death comparing i) oral anticoagulant naïve users vs. long-term oral anticoagulant users, ii) patients on anticoagulant therapy for less than 2 years (new users) vs. patients on anticoagulant therapy for more than 2 years. The material of this data article provides a better understanding on the use of oral anticoagulants in this fragile population and facilitates further critical analysis. Moreover, it aims at highlighting the importance of increasing knowledge in patients aged 90 years or older. These patients are often excluded from or under-represented in clinical trials and cohort studies. Elsevier 2019-03-01 /pmc/articles/PMC6660568/ /pubmed/31372440 http://dx.doi.org/10.1016/j.dib.2019.103794 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Medicine and Dentistry
Giustozzi, Michela
Vedovati, Maria Cristina
Verso, Melina
Scrucca, Luca
Conti, Serenella
Verdecchia, Paolo
Bogliari, Giulio
Pierpaoli, Lucia
Agnelli, Giancarlo
Becattini, Cecilia
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title_full Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title_fullStr Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title_full_unstemmed Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title_short Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
title_sort data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
topic Medicine and Dentistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660568/
https://www.ncbi.nlm.nih.gov/pubmed/31372440
http://dx.doi.org/10.1016/j.dib.2019.103794
work_keys_str_mv AT giustozzimichela dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT vedovatimariacristina dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT versomelina dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT scruccaluca dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT contiserenella dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT verdecchiapaolo dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT bogliarigiulio dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT pierpaolilucia dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT agnelligiancarlo dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation
AT becattinicecilia dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation